mitomycin has been researched along with Corneal Diseases in 110 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Corneal Diseases: Diseases of the cornea.
Excerpt | Relevance | Reference |
---|---|---|
"To report corneal toxicity of Mitomycin C application during filtering glaucoma surgery in two patients." | 7.76 | Corneal complications of intraoperative Mitomycin C in glaucoma surgery. ( Coppens, G; Maudgal, P, 2010) |
"To describe the incidence, characteristics, risk factors, and clinical outcome of limbal stem cell deficiency (LSCD) resulting from topical treatment with mitomycin C (MMC) for primary acquired melanosis (PAM) with atypia." | 7.76 | Limbal stem cell deficiency after topical mitomycin C therapy for primary acquired melanosis with atypia. ( Frucht-Pery, J; Lichtinger, A; Pe'er, J; Solomon, A, 2010) |
"To report a case of postoperative cystic epithelial downgrowth treated with needle aspiration and intralesional administration of mitomycin C." | 7.73 | Treatment of cystic epithelial downgrowth with intralesional administration of mitomycin C. ( Chiu, SI; Tse, RK; Yu, CS, 2005) |
"Pterygium excision using the bare sclera technique, phototherapeutic keratectomy, and local application of mitomycin C 0." | 7.73 | Long-term results after bare sclera pterygium resection with excimer smoothing and local application of mitomycin C. ( Daniel, J; Mennel, S; Meyer, CH; Rodrigues, EB; Walkow, T, 2005) |
"A retrospective study was undertaken to review the records of nine patients who had corneal edema and high intraocular pressure managed by simultaneous penetrating keratoplasty and trabeculectomy with mitomycin-C." | 7.69 | Management of coexisting corneal disease and glaucoma by combined penetrating keratoplasty and trabeculectomy with mitomycin-C. ( Araujo, SV; Cohen, EJ; Figueiredo, RS; Katz, LJ; Rapuano, CJ; Wilson, RP, 1996) |
"The use of topical mitomycin (mitomycin-C) as a medical adjunct to pterygium and glaucoma surgery is increasing." | 7.68 | Serious complications of topical mitomycin-C after pterygium surgery. ( Foster, CS; Martin, NF; Pfister, RR; Rubinfeld, RS; Speaker, MG; Stein, RM; Stoleru, S; Talley, AR, 1992) |
" The dosage of mitomycin-C was 0." | 5.31 | Outcome of trabeculectomy with mitomycin-C in the iridocorneal endothelial syndrome. ( Aslanides, IM; Augsburger, JJ; Dudley, D; Lanzl, IM; Spaeth, GL; Wilson, RP, 2000) |
" Although topical mitomycin-C is effective as an adjunct to pterygium surgery and may reduce recurrence, the safety and efficacy of various concentrations and dosing schedules need further definition." | 5.29 | Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin-C. ( Dougherty, PJ; Hardten, DR; Lindstrom, RL, 1996) |
"To evaluate ocular straylight before and after photorefractive keratectomy (PRK) for low myopia with and without topical mitomycin (MMC) treatment." | 5.22 | Intraocular straylight before and after low myopic photorefractive keratectomy with and without mitomycin C. ( Bechara, SJ; Crestana, FP; Netto, MV; Parede, TR; Torricelli, AA, 2016) |
"To evaluate the efficacy and safety of application of mitomycin-C (MMC) in combined and separate trabeculectomy and penetrating keratoplasty for the treatment of coexisting corneal disease and glaucoma." | 5.09 | Mitomycin-C in combined or two-stage procedure trabeculectomy followed by penetrating keratoplasty. ( Chowers, I; Ticho, U, 1999) |
"Ethanol and mitomycin C (MMC) are clinically used to treat corneal diseases such as LASEK and LASIK surgery." | 4.31 | Evaluation of the effects of ethanol and mitomycin on survival of rat limbal stem cells: an in vitro study. ( Bayati, V; Nasrolahi, A; Nejaddehbashi, F; Zamani, M, 2023) |
"This study was undertaken to evaluate the efficacy of co-treatment with suberoylanilide hydroxamic acid (SAHA) and mitomycin-C (MMC) on corneal fibrosis in an in-vivo model." | 3.80 | The efficacy of co-treatment with suberoylanilide hydroxamic acid and mitomycin C on corneal scarring after therapeutic keratectomy: an animal study. ( Kim, SW; Park, WC; Woo, JE; Yoo, YH, 2014) |
"To describe the incidence, characteristics, risk factors, and clinical outcome of limbal stem cell deficiency (LSCD) resulting from topical treatment with mitomycin C (MMC) for primary acquired melanosis (PAM) with atypia." | 3.76 | Limbal stem cell deficiency after topical mitomycin C therapy for primary acquired melanosis with atypia. ( Frucht-Pery, J; Lichtinger, A; Pe'er, J; Solomon, A, 2010) |
"Persistent epitheliopathy, presumably resulting from limbal stem cell deficiency, is an uncommon complication of treatment of conjunctival malignant melanoma with surgical excision, cryotherapy, and mitomycin C." | 3.76 | Boston Ocular Surface Prosthesis for persistent epitheliopathy after treatment of conjunctival melanoma. ( Colby, KA; Grover, S; Jacobs, DS, 2010) |
"To report corneal toxicity of Mitomycin C application during filtering glaucoma surgery in two patients." | 3.76 | Corneal complications of intraoperative Mitomycin C in glaucoma surgery. ( Coppens, G; Maudgal, P, 2010) |
"Inflammation was controlled with topical steroids and the patient underwent a combined phacoemulsification and trabeculectomy with mitomycin-C for uncontrolled glaucoma." | 3.73 | Corneal honeybee sting. ( Fam, HB; Lee, JJ; Teoh, SC, 2005) |
"The routine use of mitomycin C to enhance glaucomatous filtering surgery has found wide acceptance." | 3.73 | Bullous keratopathy as a complication of trabeculectomy with mitomycin C. ( Krieglstein, GK; Mietz, H; Roters, S, 2005) |
"Pterygium excision using the bare sclera technique, phototherapeutic keratectomy, and local application of mitomycin C 0." | 3.73 | Long-term results after bare sclera pterygium resection with excimer smoothing and local application of mitomycin C. ( Daniel, J; Mennel, S; Meyer, CH; Rodrigues, EB; Walkow, T, 2005) |
"To report a case of postoperative cystic epithelial downgrowth treated with needle aspiration and intralesional administration of mitomycin C." | 3.73 | Treatment of cystic epithelial downgrowth with intralesional administration of mitomycin C. ( Chiu, SI; Tse, RK; Yu, CS, 2005) |
"Mitomycin-C use may lead to lacrimal apparatus fibrosis and symptomatic epiphora when inciting a toxoallergic reaction." | 3.72 | Punctal-canalicular stenosis associated with mitomycin-C for corneal epithelial dysplasia. ( Billing, K; Karagiannis, A; Selva, D, 2003) |
"To evaluate corneal graft survival and intraocular pressure control in eyes that have undergone combined penetrating keratoplasty and trabeculectomy with mitomycin C (MMC)." | 3.70 | Combined penetrating keratoplasty and trabeculectomy with mitomycin C. ( Alfonso, E; Palmberg, PF; WuDunn, D, 1999) |
"A retrospective study was undertaken to review the records of nine patients who had corneal edema and high intraocular pressure managed by simultaneous penetrating keratoplasty and trabeculectomy with mitomycin-C." | 3.69 | Management of coexisting corneal disease and glaucoma by combined penetrating keratoplasty and trabeculectomy with mitomycin-C. ( Araujo, SV; Cohen, EJ; Figueiredo, RS; Katz, LJ; Rapuano, CJ; Wilson, RP, 1996) |
"The use of topical mitomycin (mitomycin-C) as a medical adjunct to pterygium and glaucoma surgery is increasing." | 3.68 | Serious complications of topical mitomycin-C after pterygium surgery. ( Foster, CS; Martin, NF; Pfister, RR; Rubinfeld, RS; Speaker, MG; Stein, RM; Stoleru, S; Talley, AR, 1992) |
" Regarding adverse effects, one or more mild adverse reaction occurred in 77% of patients managed with MMC and in 50% of patients managed with IFNα2b (p > 0." | 3.30 | Safety and efficacy of topical interferon alpha 2B and mitomycin C for localized conjunctival intraepithelial neoplasia: long-term report of their pharmacological safety and efficacy. ( Alvarado-Castillo, B; Garcia-Benavides, L; Gonzalez-Castillo, C; Navarro-Partida, J; Rosales-Gradilla, ME; Santa Cruz-Pavlovich, FJ; Vidal-Paredes, IA, 2023) |
"Mitomycin C (MMC) was introduced as a healing modulator and applied on the corneal surface after refractive surgery to address these drawbacks." | 2.61 | A Critical Overview of the Biological Effects of Mitomycin C Application on the Cornea Following Refractive Surgery. ( Arranz-Marquez, E; Katsanos, A; Konstas, AGP; Kozobolis, VP; Teus, MA, 2019) |
"Mitomycin C has been shown in studies to be highly effective but has short-term and long-term side-effects that may be intolerable." | 2.49 | Topical chemotherapy for ocular surface squamous neoplasia. ( Karp, CL; Nanji, AA; Sayyad, FE, 2013) |
"That MMC safely and effectively reduced scarring in ECF by reducing the degree of transdifferentiation of corneal fibroblasts to myofibroblasts in vitro." | 1.36 | Efficacy and safety of mitomycin C as an agent to treat corneal scarring in horses using an in vitro model. ( Buss, DG; Giuliano, EA; Mohan, RR; Sharma, A, 2010) |
"In the normal dosage group the mean total dose of 5 FU was 25." | 1.36 | [Corneal epitheliopathy following trabeculectomy with postoperative adjunctive 5-fluorouracil]. ( Geerling, G; Grehn, F; Klink, T; Reiter, C; Schultheiss, A; Wimmer, S, 2010) |
"Primary corneal squamous cell carcinoma with no history of keratoconjunctivitis sicca is rare in dogs." | 1.35 | Superficial keratectomy and topical mitomycin C as therapy for a corneal squamous cell carcinoma in a dog. ( Karasawa, K; Matsuda, H; Tanaka, A, 2008) |
"To report a case of isolated squamous cell carcinoma of cornea." | 1.35 | Squamous cell carcinoma of cornea. ( Arya, SK; Gupta, H; Gupta, S; Malik, A; Samra, SG; Sood, S, 2008) |
"Atopic keratoconjunctivitis (AKC) and vernal keratoconjunctivitis (VKC) are chronic inflammatory allergic diseases that are associated with some common conjunctival and corneal complications." | 1.33 | Quantitative evaluation of the early changes in ocular surface inflammation following MMC-aided papillary resection in severe allergic patients with corneal complications. ( Asano-Kato, N; Dogru, M; Fujishima, H; Fukagawa, K; Miyake-Kashima, M; Takano, Y; Tanaka, M; Tsubota, K, 2006) |
"To determine the efficiency of topical cyclosporine-A (CSA) combined with mitomycin C (MMC) as an adjunctive treatment in diffuse conjunctival and corneal squamous cell carcinoma (CCSC)." | 1.33 | Topical cyclosporine-a combined with mitomycin C for conjunctival and corneal squamous cell carcinoma. ( Erbilen, E; Tunc, M, 2006) |
"A case of early-onset sclerolimbal ectasia following low-dose topical mitomycin C application during uveitic glaucoma surgery is reported." | 1.33 | Early-onset scleral and corneal ectasias following low-dose mitomycin-C-augmented trabeculectomy in a uveitic glaucoma patient. ( Jockin, Y; O'Halloran, H; Pirouzian, A; Scher, C, 2006) |
" The dosage of mitomycin-C was 0." | 1.31 | Outcome of trabeculectomy with mitomycin-C in the iridocorneal endothelial syndrome. ( Aslanides, IM; Augsburger, JJ; Dudley, D; Lanzl, IM; Spaeth, GL; Wilson, RP, 2000) |
"DNA cytometry showed nonaneuploidy in all of these." | 1.30 | Cytologic and DNA cytometric diagnosis and therapy monitoring of squamous cell carcinoma in situ and malignant melanoma of the cornea and conjunctiva. ( Böcking, A; Kersten, A; Krallmann, R; Motherby, H; Nadjari, B; Ross, B; Sundmacher, R, 1999) |
" Although topical mitomycin-C is effective as an adjunct to pterygium surgery and may reduce recurrence, the safety and efficacy of various concentrations and dosing schedules need further definition." | 1.29 | Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin-C. ( Dougherty, PJ; Hardten, DR; Lindstrom, RL, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 17 (15.45) | 18.2507 |
2000's | 54 (49.09) | 29.6817 |
2010's | 34 (30.91) | 24.3611 |
2020's | 5 (4.55) | 2.80 |
Authors | Studies |
---|---|
Moratal Peiro, B | 1 |
Calvo Garcia, R | 1 |
Soler Sanchis, I | 1 |
Mata Moret, L | 1 |
Cervera Taulet, E | 1 |
Bayati, V | 1 |
Nasrolahi, A | 1 |
Zamani, M | 1 |
Nejaddehbashi, F | 1 |
Alvarado-Castillo, B | 1 |
Santa Cruz-Pavlovich, FJ | 1 |
Gonzalez-Castillo, C | 1 |
Vidal-Paredes, IA | 1 |
Garcia-Benavides, L | 1 |
Rosales-Gradilla, ME | 1 |
Navarro-Partida, J | 1 |
Trufanov, SV | 1 |
Aboumourad, RJ | 1 |
Galor, A | 2 |
Karp, CL | 3 |
Wilde, C | 1 |
Messina, M | 1 |
Dua, HS | 2 |
Polski, A | 1 |
Sibug Saber, M | 1 |
Kim, JW | 1 |
Berry, JL | 1 |
Bennis, A | 1 |
Chraibi, F | 1 |
Abdellaoui, M | 1 |
Benatiya, IA | 1 |
Ma, IH | 1 |
Hu, FR | 1 |
Wang, IJ | 1 |
Chen, WL | 1 |
Hsu, YJ | 1 |
Chu, HS | 1 |
Yuan, CT | 1 |
Hou, YC | 1 |
Arranz-Marquez, E | 1 |
Katsanos, A | 1 |
Kozobolis, VP | 2 |
Konstas, AGP | 1 |
Teus, MA | 1 |
Nanji, AA | 1 |
Sayyad, FE | 1 |
Ono, T | 1 |
Yuki, K | 1 |
Ozeki, N | 1 |
Shiba, D | 1 |
Tsubota, K | 3 |
Lee, JH | 1 |
Kim, YH | 1 |
Kim, MS | 1 |
Kim, EC | 1 |
Kim, BH | 1 |
Kim, MK | 1 |
Wee, WR | 1 |
Oh, JY | 1 |
Besley, J | 1 |
Pappalardo, J | 1 |
Lee, GA | 1 |
Hirst, LW | 2 |
Vincent, SJ | 1 |
Woo, JE | 1 |
Park, WC | 1 |
Yoo, YH | 1 |
Kim, SW | 1 |
Lang, SJ | 1 |
Böhringer, D | 2 |
Reinhard, T | 3 |
Reddy, JC | 1 |
Rapuano, CJ | 3 |
Felipe, AF | 1 |
Nagra, PK | 1 |
Hammersmith, KM | 2 |
Cherof, AM | 1 |
SooHoo, JR | 1 |
Kahook, MY | 1 |
Seibold, LK | 1 |
Vazirani, J | 1 |
Mohapatra, S | 1 |
Torricelli, AA | 1 |
Parede, TR | 1 |
Netto, MV | 2 |
Crestana, FP | 1 |
Bechara, SJ | 1 |
Hau, S | 1 |
Barton, K | 1 |
Guthoff, RF | 1 |
Zhivov, A | 1 |
Stachs, O | 1 |
Boto-de-Los-Bueis, A | 1 |
Díaz-Valle, D | 1 |
Llorente-González, S | 1 |
Pastora-Salvador, N | 1 |
Patrón-Romero, M | 1 |
Hernández-González, C | 1 |
Gentile, CM | 1 |
Burchakchi, AI | 1 |
Oscar, CJ | 1 |
Ma, JJ | 1 |
Tseng, SS | 1 |
Yarascavitch, BA | 1 |
Zaki, AA | 1 |
Farid, SF | 1 |
Rudkin, AK | 1 |
Muecke, JS | 1 |
Ramasubramanian, A | 1 |
Shields, CL | 3 |
Sinha, N | 1 |
Shields, JA | 3 |
Lichtinger, A | 1 |
Pe'er, J | 3 |
Frucht-Pery, J | 3 |
Solomon, A | 1 |
Grover, S | 1 |
Jacobs, DS | 1 |
Colby, KA | 1 |
Gupta, A | 1 |
Muecke, J | 2 |
Coppens, G | 1 |
Maudgal, P | 1 |
Buss, DG | 2 |
Sharma, A | 1 |
Giuliano, EA | 2 |
Mohan, RR | 2 |
Colby, K | 1 |
Bhat, P | 1 |
Novais, G | 1 |
Jakobiec, FA | 1 |
Birkholz, ES | 1 |
Goins, KM | 1 |
Sutphin, JE | 2 |
Kitzmann, AS | 1 |
Wagoner, MD | 1 |
Reiter, C | 1 |
Wimmer, S | 1 |
Schultheiss, A | 1 |
Klink, T | 1 |
Grehn, F | 1 |
Geerling, G | 1 |
Sugandhi, P | 1 |
George, RE | 1 |
Gokhale, NS | 1 |
Eberwein, P | 2 |
Gupta, R | 1 |
Yarnall, BW | 1 |
Kanwar, JR | 1 |
Gonçalves, ED | 1 |
Paris, Fdos S | 1 |
Gomes, JÁ | 1 |
Kanecadan, L | 1 |
Campos, M | 1 |
Santhiago, MR | 1 |
Wilson, SE | 1 |
Schwartzkopff, J | 1 |
Birnbaum, F | 1 |
Oellers, P | 1 |
Kao, AA | 1 |
Abdelaziz, A | 1 |
Feuer, W | 1 |
Dubovy, SR | 1 |
Yang, PT | 1 |
Tucker, NA | 1 |
Rootman, DB | 1 |
Rootman, DS | 1 |
McGowan, H | 1 |
Chan, CC | 1 |
Papandroudis, AA | 1 |
Dimitrakos, SA | 1 |
Stangos, NT | 1 |
Price, FW | 2 |
Panda, A | 2 |
Bajaj, MS | 1 |
Balasubramanya, R | 1 |
Prakash, G | 1 |
Bowers, PJ | 1 |
Price, MO | 1 |
Zeldes, SS | 1 |
Dogru, M | 2 |
Erturk, H | 1 |
Shimazaki, J | 1 |
Gul, M | 1 |
Billing, K | 1 |
Karagiannis, A | 1 |
Selva, D | 1 |
Di Pascuale, MA | 1 |
Espana, EM | 1 |
Tseng, SC | 1 |
Dudney, BW | 1 |
Malecha, MA | 1 |
Stone, DU | 1 |
Butt, AL | 1 |
Chodosh, J | 1 |
Walkow, T | 1 |
Daniel, J | 1 |
Meyer, CH | 1 |
Rodrigues, EB | 1 |
Mennel, S | 1 |
Prabhasawat, P | 1 |
Tarinvorakup, P | 1 |
Tesavibul, N | 1 |
Uiprasertkul, M | 1 |
Kosrirukvongs, P | 1 |
Booranapong, W | 1 |
Srivannaboon, S | 1 |
Mietz, H | 1 |
Roters, S | 1 |
Krieglstein, GK | 1 |
Teoh, SC | 1 |
Lee, JJ | 1 |
Fam, HB | 1 |
Yu, CS | 1 |
Chiu, SI | 1 |
Tse, RK | 1 |
Laria-Ochaita, C | 1 |
Alió-y-Sanz, JL | 1 |
Taneri, S | 1 |
Koch, JM | 1 |
Melki, SA | 1 |
Azar, DT | 2 |
Epstein, RJ | 2 |
Majmudar, PA | 2 |
Tanaka, M | 1 |
Takano, Y | 1 |
Miyake-Kashima, M | 1 |
Asano-Kato, N | 1 |
Fukagawa, K | 1 |
Fujishima, H | 1 |
Khong, JJ | 1 |
Sauder, G | 1 |
Jonas, JB | 1 |
Finger, PT | 1 |
Ayres, BD | 1 |
Laibson, PR | 1 |
Tunc, M | 1 |
Erbilen, E | 1 |
Pirouzian, A | 1 |
O'Halloran, H | 1 |
Scher, C | 1 |
Jockin, Y | 1 |
Ou, JI | 1 |
Manche, EE | 2 |
Huerva, V | 1 |
Mateo, AJ | 1 |
Mangues, I | 1 |
Jurjo, C | 1 |
Karasawa, K | 1 |
Matsuda, H | 1 |
Tanaka, A | 1 |
Arya, SK | 1 |
Malik, A | 1 |
Samra, SG | 1 |
Gupta, S | 2 |
Gupta, H | 1 |
Sood, S | 1 |
Kuo, IC | 1 |
Jabbur, NS | 1 |
O'Brien, TP | 1 |
Aggarwal, A | 1 |
Das, H | 1 |
Kumar, A | 1 |
Mohan, S | 1 |
Nassiri, N | 2 |
Farahangiz, S | 1 |
Rahnavardi, M | 1 |
Rahmani, L | 1 |
Balestrazzi, A | 1 |
Martone, G | 1 |
Pichierri, P | 1 |
Tosi, GM | 1 |
Caporossi, A | 1 |
Rozenman, Y | 2 |
Dougherty, PJ | 1 |
Hardten, DR | 1 |
Lindstrom, RL | 1 |
Figueiredo, RS | 1 |
Araujo, SV | 1 |
Cohen, EJ | 1 |
Katz, LJ | 1 |
Wilson, RP | 2 |
Tseng, SH | 1 |
Tsai, YY | 1 |
Chen, FK | 1 |
Löffler, KU | 1 |
Sugar, J | 1 |
Baum, J | 1 |
Savir, H | 1 |
Holland, EJ | 1 |
Meisler, DM | 1 |
Foster, JA | 1 |
Folberg, R | 1 |
Wilson, MW | 2 |
Hungerford, JL | 1 |
George, SM | 1 |
Madreperla, SA | 1 |
Gebhardt, DO | 1 |
Afshari, MA | 1 |
Singh, K | 1 |
WuDunn, D | 1 |
Alfonso, E | 1 |
Palmberg, PF | 1 |
Haas, K | 1 |
Ben-Dor, D | 1 |
Levartovsky, S | 1 |
Chowers, I | 1 |
Ticho, U | 1 |
Nadjari, B | 1 |
Kersten, A | 1 |
Ross, B | 1 |
Motherby, H | 1 |
Krallmann, R | 1 |
Sundmacher, R | 1 |
Böcking, A | 1 |
Lanzl, IM | 1 |
Dudley, D | 1 |
Augsburger, JJ | 1 |
Aslanides, IM | 1 |
Spaeth, GL | 1 |
Schelonka, LP | 1 |
Siegel, D | 1 |
Meininger, A | 1 |
Ross, D | 1 |
Lin, CP | 1 |
Liu, YT | 1 |
Chen, CW | 1 |
Raviv, T | 1 |
Dennis, RF | 1 |
Jain, S | 1 |
McCally, RL | 1 |
Connolly, PJ | 1 |
Joseph, A | 1 |
Sabri, K | 1 |
McKelvie, PA | 1 |
Daniell, M | 2 |
Doe, EA | 1 |
Budenz, DL | 1 |
Gedde, SJ | 1 |
Imami, NR | 1 |
Armstrong, T | 1 |
Siganos, CS | 1 |
Christodoulakis, EV | 1 |
Khokhar, S | 1 |
Soni, A | 1 |
SinghSethi, H | 1 |
Sudan, R | 1 |
Sony, P | 1 |
Pangtey, MS | 1 |
Safianik, B | 1 |
Ben-Zion, I | 1 |
Garzozi, HJ | 1 |
Maini, R | 1 |
Tole, D | 1 |
Fukuchi, T | 1 |
Hayakawa, Y | 1 |
Hara, H | 1 |
Abe, H | 1 |
Naseripour, M | 1 |
Basti, S | 1 |
Rubinfeld, RS | 1 |
Pfister, RR | 1 |
Stein, RM | 1 |
Foster, CS | 1 |
Martin, NF | 1 |
Stoleru, S | 1 |
Talley, AR | 1 |
Speaker, MG | 1 |
Derick, RJ | 1 |
Pasquale, L | 1 |
Quigley, HA | 1 |
Jampel, H | 1 |
7 reviews available for mitomycin and Corneal Diseases
Article | Year |
---|---|
A Critical Overview of the Biological Effects of Mitomycin C Application on the Cornea Following Refractive Surgery.
Topics: Antibiotics, Antineoplastic; Cornea; Corneal Diseases; Corneal Surgery, Laser; Humans; Mitomycin; Po | 2019 |
Topical chemotherapy for ocular surface squamous neoplasia.
Topics: Administration, Topical; Antimetabolites, Antineoplastic; Carcinoma in Situ; Conjunctival Neoplasms; | 2013 |
Corneal complications of glaucoma surgery.
Topics: Corneal Diseases; Corneal Transplantation; Fluorouracil; Glaucoma; Glaucoma Drainage Implants; Graft | 2009 |
In vivo confocal microscopy, an inner vision of the cornea - a major review.
Topics: Administration, Topical; Animals; Contact Lenses; Cornea; Corneal Diseases; Diagnosis, Differential; | 2009 |
Treatment of ocular surface squamous neoplasia with Mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in Situ; Chemotherapy, Adjuva | 2010 |
[Perspectives and current state in limbal stem cell transplantation].
Topics: Amnion; Corneal Diseases; Corneal Transplantation; Epithelial Cells; Epithelium, Corneal; Graft Reje | 2011 |
Mitomycin C: biological effects and use in refractive surgery.
Topics: Alkylating Agents; Animals; Chemotherapy, Adjuvant; Corneal Diseases; Corneal Surgery, Laser; Humans | 2012 |
10 trials available for mitomycin and Corneal Diseases
Article | Year |
---|---|
Safety and efficacy of topical interferon alpha 2B and mitomycin C for localized conjunctival intraepithelial neoplasia: long-term report of their pharmacological safety and efficacy.
Topics: Administration, Topical; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Conjunc | 2023 |
Intraocular straylight before and after low myopic photorefractive keratectomy with and without mitomycin C.
Topics: Administration, Ophthalmic; Adult; Corneal Diseases; Corneal Wavefront Aberration; Cross-Linking Rea | 2016 |
Treatment of ocular surface squamous neoplasia with Mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in Situ; Chemotherapy, Adjuva | 2010 |
Bullous keratopathy.
Topics: Blister; Combined Modality Therapy; Corneal Diseases; Corneal Transplantation; Eye Pain; Follow-Up S | 2011 |
Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia: early resolution.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in S | 2007 |
Corneal endothelial cell injury induced by mitomycin-C in photorefractive keratectomy: nonrandomized controlled trial.
Topics: Adolescent; Adult; Alkylating Agents; Cell Count; Cell Survival; Corneal Diseases; Endothelium, Corn | 2008 |
Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in S | 1997 |
Mitomycin-C in combined or two-stage procedure trabeculectomy followed by penetrating keratoplasty.
Topics: Adolescent; Adult; Aged; Chemotherapy, Adjuvant; Corneal Diseases; Female; Glaucoma; Graft Survival; | 1999 |
Use of mitomycin C in the treatment of corneal conjunctival intraepithelial neoplasia.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in S | 2002 |
Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma.
Topics: Administration, Topical; Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Conjunc | 2002 |
94 other studies available for mitomycin and Corneal Diseases
Article | Year |
---|---|
Advancing wavelike epitheliopathy after conjunctival intraepithelial neoplasia. Atipical case report.
Topics: Administration, Topical; Carcinoma in Situ; Conjunctival Neoplasms; Corneal Diseases; Humans; Mitomy | 2022 |
Evaluation of the effects of ethanol and mitomycin on survival of rat limbal stem cells: an in vitro study.
Topics: Animals; Corneal Diseases; Ethanol; Limbal Stem Cells; Male; Mitomycin; Rats; Rats, Wistar | 2023 |
[Lamellar keratoplasty in the management of recurrent pterygium].
Topics: Conjunctiva; Corneal Diseases; Corneal Transplantation; Humans; Mitomycin; Pterygium | 2020 |
Case Series: High-resolution Optical Coherence Tomography as an Optical Biopsy in Ocular Surface Squamous Neoplasia.
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Biopsy; C | 2021 |
Management of recurrent epithelial ingrowth following laser in situ keratomileusis with mechanical debridement, alcohol, mitomycin-C, and fibrin glue.
Topics: Corneal Diseases; Debridement; Epithelium, Corneal; Ethanol; Fibrin Tissue Adhesive; Humans; Keratom | 2017 |
Extending far and wide: the role of biopsy and staging in the management of ocular surface squamous neoplasia.
Topics: Aged; Antineoplastic Agents; Biopsy; Carcinoma, Squamous Cell; Conjunctival Neoplasms; Corneal Disea | 2019 |
[Invasive squamous cell carcinoma of the cornea treated with mitomycin eye drops].
Topics: Carcinoma, Squamous Cell; Corneal Diseases; Corneal Neovascularization; Eye Neoplasms; Humans; Insti | 2018 |
Clinicopathologic correlation of ocular surface squamous neoplasia from a university hospital in North Taiwan 1994 to 2014.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Conjunctival Neopla | 2019 |
Ocular surface complications after trabeculectomy: incidence, risk factors, time course and prognosis.
Topics: Alkylating Agents; Corneal Diseases; Female; Glaucoma; Humans; Incidence; Male; Middle Aged; Mitomyc | 2013 |
The effect of surgical wide excision and amniotic membrane transplantation with adjuvant topical mitomycin C treatment in recurrent conjunctival--corneal intraepithelial neoplasia.
Topics: Aged; Alkylating Agents; Amnion; Carcinoma in Situ; Combined Modality Therapy; Conjunctival Neoplasm | 2014 |
Clinical and pathological characteristics of ocular surface squamous neoplasia in an Asian population.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Asian People; Carcinoma in Situ; Carcinoma, S | 2013 |
Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoc | 2014 |
The efficacy of co-treatment with suberoylanilide hydroxamic acid and mitomycin C on corneal scarring after therapeutic keratectomy: an animal study.
Topics: Animals; Apoptosis; Blotting, Western; Cell Line; Cell Survival; Cicatrix; Corneal Diseases; Cytokin | 2014 |
Surgical management of corneal limbal dermoids: retrospective study of different techniques and use of Mitomycin C.
Topics: Alkylating Agents; Amnion; Child; Child, Preschool; Combined Modality Therapy; Corneal Diseases; Der | 2014 |
Quality of vision after excimer laser phototherapeutic keratectomy with intraoperative mitomycin-C for Salzmann nodular degeneration.
Topics: Adult; Aged; Alkylating Agents; Contrast Sensitivity; Corneal Diseases; Corneal Topography; Corneal | 2014 |
Endophthalmitis With Corneal Infiltrate After EX-PRESS Glaucoma Drainage Device Implantation.
Topics: Alkylating Agents; Anti-Bacterial Agents; Corneal Diseases; Device Removal; Drug Combinations; Endop | 2016 |
Ocular Surface Squamous Neoplasia.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Conjunctival Neoplasms; Corneal Disease | 2016 |
[Post-traumatic striate melanokeratosis in a Caucasian woman].
Topics: Conjunctival Diseases; Corneal Diseases; Corneal Ulcer; Eye Color; Female; Fluorometholone; Humans; | 2009 |
In vivo confocal microscopy study of ocular surface neoplasia manifesting after radial keratotomy and laser in situ keratomileusis.
Topics: Carcinoma in Situ; Carcinoma, Squamous Cell; Combined Modality Therapy; Conjunctival Neoplasms; Corn | 2009 |
Anterior segment optical coherence tomography for transepithelial phototherapeutic keratectomy in central corneal stromal scarring.
Topics: Anterior Eye Segment; Cicatrix; Corneal Diseases; Corneal Opacity; Corneal Stroma; Epithelium, Corne | 2009 |
Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up.
Topics: Aged; Carcinoma in Situ; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy | 2009 |
Topical mitomycin following cryotherapy for treatment of recurrent ocular surface melanoma.
Topics: Administration, Topical; Aged, 80 and over; Antibiotics, Antineoplastic; Combined Modality Therapy; | 2009 |
Ocular surface squamous neoplasia after corneal graft.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Corneal Diseases | 2010 |
Limbal stem cell deficiency after topical mitomycin C therapy for primary acquired melanosis with atypia.
Topics: Administration, Topical; Adult; Aged; Antibiotics, Antineoplastic; Cell Count; Conjunctival Diseases | 2010 |
Boston Ocular Surface Prosthesis for persistent epitheliopathy after treatment of conjunctival melanoma.
Topics: Aged; Alkylating Agents; Artificial Organs; Conjunctival Neoplasms; Corneal Diseases; Epithelium, Co | 2010 |
Corneal complications of intraoperative Mitomycin C in glaucoma surgery.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Antifibrinolytic Agents; Corneal Diseases; Epithelium, C | 2010 |
Efficacy and safety of mitomycin C as an agent to treat corneal scarring in horses using an in vitro model.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Blotting, Western; Cells, Cultured; Cicatrix; Corne | 2010 |
Recurrent primary acquired melanosis with atypia involving a clear corneal phacoemulsification wound.
Topics: Aged, 80 and over; Alkylating Agents; Combined Modality Therapy; Cornea; Corneal Diseases; Cryothera | 2011 |
Treatment of ocular surface squamous cell intraepithelial neoplasia with and without mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Biopsy; Carcinoma in Situ; Chemotherapy | 2011 |
[Corneal epitheliopathy following trabeculectomy with postoperative adjunctive 5-fluorouracil].
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Combined Modality Therapy; Corne | 2010 |
Use of combination therapy of topical mitomycin C and cyclosporine a as an adjunct to surgery for corneal and conjunctival intraepithelial neoplasia and invasive squamous cell carcinoma.
Topics: Administration, Topical; Carcinoma in Situ; Carcinoma, Squamous Cell; Combined Modality Therapy; Con | 2011 |
Mitomycin C therapy for corneal intraepithelial neoplasia masquerading as limbal stem cell deficiency with recurrent epithelial defect.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Carcinoma in Situ; Corneal Diseases; Diagnosis | 2011 |
Mitomycin C: a promising agent for the treatment of canine corneal scarring.
Topics: Actins; Animals; Apoptosis; Cicatrix; Corneal Diseases; Corneal Keratocytes; Dog Diseases; Dogs; Dos | 2011 |
Allogenic limbo-keratoplasty with conjunctivoplasty, mitomycin C, and amniotic membrane for bilateral limbal stem cell deficiency.
Topics: Adult; Alkylating Agents; Amnion; Conjunctiva; Corneal Diseases; Cyclosporine; Female; Follow-Up Stu | 2012 |
Predictors of ocular surface squamous neoplasia recurrence after excisional surgery.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma in Situ; Carcinoma, Squamous Cell; Conjunctival Neoplasms; | 2012 |
Pagetoid spread of sebaceous cell carcinoma to the cornea.
Topics: Adenocarcinoma, Sebaceous; Administration, Topical; Antibiotics, Antineoplastic; Biopsy; Conjunctiva | 2012 |
Mitomycin C therapy for conjunctival-corneal intraepithelial neoplasia.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma in Situ; Conjunctival Neoplasms; Corneal Diseases; Eye | 2002 |
Corneal endothelial damage after trabeculectomy with mitomycin C in two patients with glaucoma with cornea guttata.
Topics: Corneal Diseases; Endothelium, Corneal; Glaucoma; Humans; Mitomycin; Trabeculectomy | 2002 |
Topical mitomycin C for conjunctival-corneal squamous cell carcinoma.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Conjunctival Neoplas | 2003 |
Superficial keratectomy with mitomycin-C for the treatment of Salzmann's nodules.
Topics: Adult; Aged; Aged, 80 and over; Cicatrix; Cornea; Corneal Diseases; Female; Follow-Up Studies; Human | 2003 |
Tear function and ocular surface changes with topical mitomycin (MMC) treatment for primary corneal intraepithelial neoplasia.
Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Cell Count; Conjunctiva; Cornea; Corneal | 2003 |
Punctal-canalicular stenosis associated with mitomycin-C for corneal epithelial dysplasia.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Corneal Diseases; Female; Fibrosis; Humans; La | 2003 |
A case of conjunctiva-cornea intraepithelial neoplasia successfully treated with topical mitomycin C and interferon alfa-2b in cycles.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma in Situ; Conj | 2004 |
Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in Situ; Co | 2004 |
Ocular surface squamous neoplasia: a standard of care survey.
Topics: Administration, Topical; Antineoplastic Agents; Biopsy; Combined Modality Therapy; Conjunctival Neop | 2005 |
Long-term results after bare sclera pterygium resection with excimer smoothing and local application of mitomycin C.
Topics: Corneal Diseases; Eye Diseases; Follow-Up Studies; Granuloma; Humans; Laser Therapy; Lasers, Excimer | 2005 |
Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma.
Topics: Administration, Topical; Adult; Aged; Antibiotics, Antineoplastic; Carcinoma in Situ; Carcinoma, Squ | 2005 |
Bullous keratopathy as a complication of trabeculectomy with mitomycin C.
Topics: Adult; Corneal Diseases; Endothelium, Corneal; Follow-Up Studies; Glaucoma; Glucocorticoids; Humans; | 2005 |
Corneal honeybee sting.
Topics: Aged; Animals; Bees; Corneal Diseases; Corneal Injuries; Eye Foreign Bodies; Glaucoma; Humans; Insec | 2005 |
Treatment of cystic epithelial downgrowth with intralesional administration of mitomycin C.
Topics: Antibiotics, Antineoplastic; Cataract Extraction; Combined Modality Therapy; Corneal Diseases; Cysts | 2005 |
[Corneal intra-epithelial neoplasia (CIN). Treatment by combined excision and antimetabolite therapy].
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in Situ; Combined Modality Therapy; | 2005 |
Mitomycin-C assisted photorefractive keratectomy in the treatment of buttonholed laser in situ keratomileusis flaps associated with epithelial ingrowth.
Topics: Adult; Anti-Bacterial Agents; Cicatrix; Cornea; Corneal Diseases; Corneal Surgery, Laser; Drug Thera | 2005 |
Alternative approach to the treatment of subepithelial fibrosis following radial keratotomy.
Topics: Antibiotics, Antineoplastic; Corneal Diseases; Epithelium, Corneal; Fibrosis; Humans; Keratotomy, Ra | 2006 |
Quantitative evaluation of the early changes in ocular surface inflammation following MMC-aided papillary resection in severe allergic patients with corneal complications.
Topics: Adolescent; Adult; Alkylating Agents; Child; Combined Modality Therapy; Conjunctivitis, Allergic; Co | 2006 |
Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia.
Topics: Adenocarcinoma, Sebaceous; Antibiotics, Antineoplastic; Carcinoma in Situ; Carcinoma, Squamous Cell; | 2006 |
Limbal stem cell deficiency after subconjunctival mitomycin C injection for trabeculectomy.
Topics: Antibiotics, Antineoplastic; Conjunctiva; Corneal Diseases; Humans; Injections; Limbus Corneae; Mito | 2006 |
Topical mitomycin chemotherapy for malignant conjunctival and corneal neoplasia.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Conjunctival Neoplasms; Corneal Diseases; Drug | 2006 |
Phototherapeutic keratectomy with intraoperative mitomycin C to prevent recurrent anterior corneal pathology.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Child; Combined Modality Th | 2006 |
Topical cyclosporine-a combined with mitomycin C for conjunctival and corneal squamous cell carcinoma.
Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Conjunctival N | 2006 |
Early-onset scleral and corneal ectasias following low-dose mitomycin-C-augmented trabeculectomy in a uveitic glaucoma patient.
Topics: Adolescent; Alkylating Agents; Combined Modality Therapy; Corneal Diseases; Dilatation, Pathologic; | 2006 |
Superficial keratectomy after epi-LASIK.
Topics: Adult; Corneal Diseases; Corneal Stroma; Corneal Topography; Female; Humans; Intraoperative Complica | 2006 |
Short-term mitomycin C followed by long-term interferon alpha2beta for conjunctiva-cornea intraepithelial neoplasia.
Topics: Administration, Topical; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; | 2006 |
Superficial keratectomy and topical mitomycin C as therapy for a corneal squamous cell carcinoma in a dog.
Topics: Administration, Topical; Animals; Carcinoma, Squamous Cell; Combined Modality Therapy; Corneal Disea | 2008 |
Squamous cell carcinoma of cornea.
Topics: Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; | 2008 |
Photorefractive keratectomy for refractory laser in situ keratomileusis flap striae.
Topics: Adult; Combined Modality Therapy; Corneal Diseases; Corneal Stroma; Corneal Topography; Female; Huma | 2008 |
Effect of topical mitomycin C on corneal endothelium.
Topics: Administration, Topical; Adult; Aged; Alkylating Agents; Cell Count; Corneal Diseases; Endothelium, | 2008 |
Corneal invasion of ocular surface squamous neoplasia after clear corneal phacoemulsification: in vivo confocal microscopy analysis.
Topics: Antibiotics, Antineoplastic; Carcinoma in Situ; Cornea; Corneal Diseases; Eye Neoplasms; Humans; Mal | 2008 |
Mitomycin C therapy for corneal intraepithelial neoplasia.
Topics: Administration, Topical; Adult; Carcinoma in Situ; Corneal Diseases; Eye Neoplasms; Female; Humans; | 1994 |
Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin-C.
Topics: Chemotherapy, Adjuvant; Contraindications; Corneal Diseases; Eye Injuries, Penetrating; Humans; Intr | 1996 |
Management of coexisting corneal disease and glaucoma by combined penetrating keratoplasty and trabeculectomy with mitomycin-C.
Topics: Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Child; Corneal Diseases; Female; Follow-Up Studies; | 1996 |
Successful treatment of recurrent corneal intraepithelial neoplasia with topical mitomycin C.
Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Carcinoma in Situ; Corneal Diseases; Eye | 1997 |
[Mitomycin as local therapeutic drug in ocular neoplasms].
Topics: Antibiotics, Antineoplastic; Conjunctival Neoplasms; Corneal Diseases; Eye Neoplasms; Follow-Up Stud | 1997 |
Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in Situ; Conjunctival Neoplas | 1997 |
Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Carcinoma in Situ; Conjunctival Neoplasms; Cor | 1998 |
Delayed corneal epitheliopathy after antimetabolite-augmented trabeculectomy.
Topics: Aged; Antimetabolites; Cornea; Corneal Diseases; Epithelium; Female; Fluorouracil; Humans; Mitomycin | 1998 |
Combined penetrating keratoplasty and trabeculectomy with mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Corneal Diseases; Female; Glaucoma; Graft Survival; Humans; Intraocu | 1999 |
Treatment of conjunctival corneal intraepithelial neoplasia with topical mitomycin C.
Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Carcinoma in Situ; Conjunctival Neoplasm | 1999 |
Cytologic and DNA cytometric diagnosis and therapy monitoring of squamous cell carcinoma in situ and malignant melanoma of the cornea and conjunctiva.
Topics: Aneuploidy; Antibiotics, Antineoplastic; Carcinoma in Situ; Carcinoma, Squamous Cell; Conjunctival N | 1999 |
Outcome of trabeculectomy with mitomycin-C in the iridocorneal endothelial syndrome.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Combined Modality Therapy; Corneal Diseases; Endothelium, | 2000 |
Immunohistochemical localization of NQO1 in epithelial dysplasia and neoplasia and in donor eyes.
Topics: Antibodies, Monoclonal; Carcinoma in Situ; Carcinoma, Squamous Cell; Conjunctiva; Conjunctival Neopl | 2000 |
Corneal ectasia after trabeculectomy with mitomycin C application.
Topics: Antibiotics, Antineoplastic; Corneal Diseases; Dilatation, Pathologic; Humans; Male; Middle Aged; Mi | 1999 |
Subepithelial fibrosis after RK.
Topics: Alkylating Agents; Corneal Diseases; Debridement; Epithelium, Corneal; Fibrosis; Humans; Keratotomy, | 2000 |
Mitomycin C reduces corneal light scattering after excimer keratectomy.
Topics: Alkylating Agents; Animals; Cicatrix; Cornea; Corneal Diseases; Drug Evaluation, Preclinical; Intrao | 2001 |
Surgical excision, autolimbal transplantation, and mitomycin C in the treatment of conjunctival and corneal intraepithelial neoplasia.
Topics: Adult; Carcinoma in Situ; Combined Modality Therapy; Conjunctival Neoplasms; Corneal Diseases; Corne | 2001 |
Impression cytology following mitomycin C therapy for ocular surface squamous neoplasia.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Apoptosis; Carcinoma, Squamous Cell; Conjunctival Neoplasm | 2001 |
Long-term surgical outcomes of patients with glaucoma secondary to the iridocorneal endothelial syndrome.
Topics: Adult; Antihypertensive Agents; Corneal Diseases; Endothelium, Corneal; Fluorouracil; Follow-Up Stud | 2001 |
Management of conjunctival and corneal melanoma with surgical excision, amniotic membrane allograft, and topical chemotherapy.
Topics: Adult; Amnion; Antibiotics, Antineoplastic; Combined Modality Therapy; Conjunctival Neoplasms; Corne | 2001 |
The intraoperative use of mitomycin-C in excision of ocular surface neoplasia with or without limbal autograft transplantation.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma in Situ; Carcinoma, Squamous Cell; C | 2002 |
Combined surgery, cryotherapy, and mitomycin-C for recurrent ocular surface squamous neoplasia.
Topics: Adult; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; Conjunctiva | 2002 |
Serious corneoscleral complications after pterygium excision with mitomycin C.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Corneal Diseases; Humans; Male; Middle Aged; Mitomycin; Po | 2002 |
Corneal endothelial damage after trabeculectomy with mitomycin C in two patients with glaucoma with cornea guttata.
Topics: Adult; Aged; Anterior Chamber; Cell Count; Corneal Diseases; Endothelium, Corneal; Female; Glaucoma, | 2002 |
Corneoscleral, ciliary body, and vitreoretinal toxicity after excessive instillation of mitomycin C.
Topics: Adult; Ciliary Body; Corneal Diseases; Eye Diseases; Female; Humans; Mitomycin; Pterygium; Retinal D | 1992 |
Serious complications of topical mitomycin-C after pterygium surgery.
Topics: Adult; Aged; Calcinosis; Cataract; Contraindications; Corneal Diseases; Eye Diseases; Female; Humans | 1992 |
Potential toxicity of mitomycin C.
Topics: Animals; Anterior Chamber; Corneal Diseases; Injections; Mitomycin; Rabbits | 1991 |